- Home
- SRTS vs CCIF Comparison
SRTS vs CCIF Comparison
Compare SRTS & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- CCIF
- Stock Information
- Founded
- SRTS 2010
- CCIF 2011
- Country
- SRTS United States
- CCIF United States
- Employees
- SRTS N/A
- CCIF N/A
- Industry
- SRTS Medical/Dental Instruments
- CCIF Finance/Investors Services
- Sector
- SRTS Health Care
- CCIF Finance
- Exchange
- SRTS Nasdaq
- CCIF Nasdaq
- Market Cap
- SRTS 106.0M
- CCIF 110.5M
- IPO Year
- SRTS 2016
- CCIF N/A
- Fundamental
- Price
- SRTS $8.89
- CCIF $8.16
- Analyst Decision
- SRTS Strong Buy
- CCIF
- Analyst Count
- SRTS 2
- CCIF 0
- Target Price
- SRTS $12.50
- CCIF N/A
- AVG Volume (30 Days)
- SRTS 262.3K
- CCIF 76.9K
- Earning Date
- SRTS 11-14-2024
- CCIF 01-01-0001
- Dividend Yield
- SRTS N/A
- CCIF 25.90%
- EPS Growth
- SRTS N/A
- CCIF N/A
- EPS
- SRTS 0.57
- CCIF N/A
- Revenue
- SRTS $41,308,000.00
- CCIF N/A
- Revenue This Year
- SRTS $55.14
- CCIF N/A
- Revenue Next Year
- SRTS $21.75
- CCIF N/A
- P/E Ratio
- SRTS $15.62
- CCIF N/A
- Revenue Growth
- SRTS 65.62
- CCIF N/A
- 52 Week Low
- SRTS $2.05
- CCIF $7.43
- 52 Week High
- SRTS $9.20
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- SRTS 75.94
- CCIF 43.32
- Support Level
- SRTS $6.70
- CCIF $8.13
- Resistance Level
- SRTS $9.20
- CCIF $8.32
- Average True Range (ATR)
- SRTS 0.56
- CCIF 0.12
- MACD
- SRTS 0.21
- CCIF 0.00
- Stochastic Oscillator
- SRTS 89.08
- CCIF 42.86
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing primarily in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting primarily of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.